海南省性传播疾病诊治现状及防控进展
Current Status of Diagnosis and Treatment of Sexually Transmitted Diseases and the Progress in Prevention and Control in Hainan Province
DOI: 10.12677/acm.2025.1571982, PDF,    科研立项经费支持
作者: 吴海芳：海南省妇女儿童医学中心妇科，海南 海口
关键词: 性传播疾病；诊治；防控；Sexually Transmitted Diseases； Diagnosis and Treatment； Prevention and Control
摘要: 性传播疾病(Sexually transmitted diseases, STDs)仍然是中国和全球面临的一个重大的社会和公共卫生挑战。目前海南省在性传播疾病的诊治及防控方面取得了进展，然而，性病诊治规范化的普及范围不均衡，基层地区实验室诊断技术能力不足，药物耐药性增加，公众对性健康知识的缺乏，给海南地区性病的防治工作带来挑战。本文对海南地区性传播疾病的诊治现状和防控策略进行综述，为制定更有效的防治措施提供理论依据。
Abstract: Sexually transmitted diseases (STDs) remain a major social and public health challenge in China and globally. Progress has been made in the diagnosis, treatment, prevention and control of STDs in Hainan Province. However, the uneven scope of the spread of STDs diagnosis and treatment standardisation, limited laboratory diagnostic capabilities in grassroots areas, the increase in drug resistance, and the lack of public knowledge about sexual health have posed a challenge to the prevention and treatment of STDs in Hainan. This paper reviews the current status of STDs diagnosis and treatment and the prevention and control strategies in Hainan to provide a theoretical basis for the development of more effective prevention and control measures.
文章引用：吴海芳. 海南省性传播疾病诊治现状及防控进展[J]. 临床医学进展, 2025, 15(7): 246-252. https://doi.org/10.12677/acm.2025.1571982

参考文献

[1] 卢玉忠. 认识和防治性传播疾病[N]. 医药养生保健报, 2024-11-29(016).
[2] 陈思达. 基于内容分析法的1979年-2022年我国传染病防控法律文本研究[D]: [硕士学位论文]. 西安: 中国人民解放军空军军医大学, 2024.
[3] 鲁建瑜, 许琼军, 李立康. 2013-2017年海南省性病流行病学特征分析[J]. 现代预防医学, 2020, 47(9): 1547-1549+1580.
[4] 朱考考, 冯玉婷, 许玉军. 2015-2020年海南省10-19岁人群梅毒流行病学分析[J]. 中国艾滋病性病, 2022, 28(5): 588-589.
[5] 朱考考, 许玉军, 王天艺, 等. 海南省2007-2017年5种性病患者的职业和年龄分布[J]. 中国热带医学, 2020, 20(3): 249-253.
[6] 陈祥生, 姜婷婷. 我国性传播疾病的流行与防治[J]. 皮肤科学通报, 2021, 38(1): 1-7+105.
[7] 严翠婷. 性病门诊患者性病知识和行为的调查[J]. 中国医药指南, 2020, 18(19): 87-88.
[8] Klausner, J.D. (2024) Sexually Transmitted Disease Prevention, Community Engagement, and Innovation. Sexually Transmitted Diseases, 51, 585-586. [Google Scholar] [CrossRef] [PubMed]
[9] 奚艳, 唐海沁. 基层医务人员性病相关培训及诊疗的现状[J]. 中国卫生产业, 2017, 14(25): 11-14.
[10] 董春波, 樊利春, 窦倩如, 等. 海南省农村妇女生殖道感染现况调查[J]. 中国热带医学, 2020, 20(9): 822-825.
[11] 黄翠敏, 窦倩如, 孔令婉, 等. 海南省2015-2019年妇女常见病筛查及患病情况分析[J]. 中国妇幼卫生杂志, 2021, 12(1): 6-10.
[12] 范淑静, 李爱明, 谢彩霞. 门诊女性性传播疾病患者治疗情况调查分析及健康宣教对策研究[J]. 中国性科学, 2016, 25(6): 82-85.
[13] 张家晖, 岳晓丽, 李婧, 等. 全国性病监测点实验室检测能力调查[J]. 中华流行病学杂志, 2020, 41(9): 1509-1513.
[14] 柳贤勤, 冯礼明. 海南省地、县级疾控机构实验室能力状况与对策[J]. 海南医学, 2011, 22(6): 143-145.
[15] 龚衍花, 冯文, 马东. 自贸港建设下海南省医疗卫生资源配置现状及公平性研究[J]. 中国卫生经济, 2022, 41(9): 46-51.
[16] 陈绍椿, 韩燕, 张瑾, 等. 常见性传播疾病实验室检测技术研究进展[J]. 皮肤科学通报, 2021, 38(1): 83-88.
[17] 中国疾病预防控制中心性病控制中心. 性传播疾病实验室检测指南[M]. 北京: 人民卫生出版社, 2019: 186.
[18] 刘泽雨, 姜伟. 性传播疾病常见病原体核酸检出结果分析[J]. 检验医学与临床, 2018, 15(21): 3293-3296.
[19] 胡玲玲, 冯琪, 刘庆中, 等. 性传播疾病常见病原体感染特点分析[J]. 智慧健康, 2023, 9(20): 84-89.
[20] 曾芍, 张先平. 260例女性生殖道解脲支原体、沙眼衣原体耐药情况分析[J]. 中国病原生物学杂志, 2023, 18(6): 721-724+733.
[21] 甄红娇, 赵飞骏, 曾铁兵. 性传播疾病病原菌耐药性的研究进展[J]. 微生物学免疫学进展, 2017, 45(2): 78-82.
[22] 高雅, 陈璐, 高青, 等. 流动人口聚集地区重点性传播疾病发病预测与防控策略[J]. 医学与哲学(A), 2017, 38(4): 43-46.
[23] Jenkins, W.D., Vohra, S., Grundy, S. and Choat, L. (2019) Incentivized Screening to Reduce Sexually Transmitted Infection Risk and Prevalence. Sexually Transmitted Diseases, 46, 654-656. [Google Scholar] [CrossRef] [PubMed]
[24] Leichliter, J.S., Seiler, N. and Wohlfeiler, D. (2016) Sexually Transmitted Disease Prevention Policies in the United States: Evidence and Opportunities. Sexually Transmitted Diseases, 43, S113-S121. [Google Scholar] [CrossRef] [PubMed]
[25] Chen, X., Peeling, R.W., Yin, Y. and Mabey, D.C. (2011) The Epidemic of Sexually Transmitted Infections in China: Implications for Control and Future Perspectives. BMC Medicine, 9, Article No. 111. [Google Scholar] [CrossRef] [PubMed]
[26] Fasciana, T., Capra, G., Lipari, D., Firenze, A. and Giammanco, A. (2022) Sexually Transmitted Diseases: Diagnosis and Control. International Journal of Environmental Research and Public Health, 19, Article No. 5293. [Google Scholar] [CrossRef] [PubMed]
[27] Workowski, K.A. and Bachmann, L.H. (2022) Centers for Disease Control and Prevention’s Sexually Transmitted Diseases Infection Guidelines. Clinical Infectious Diseases, 74, S89-S94. [Google Scholar] [CrossRef] [PubMed]
[28] Karellis, A., Naeem, F., Nair, S., Mallya, S.D., Routy, J., Gahagan, J., et al. (2022) Multiplexed Rapid Technologies for Sexually Transmitted Infections: A Systematic Review. The Lancet Microbe, 3, e303-e315. [Google Scholar] [CrossRef] [PubMed]
[29] Caruso, G., Giammanco, A., Virruso, R. and Fasciana, T. (2021) Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections. International Journal of Environmental Research and Public Health, 18, Article No. 1038. [Google Scholar] [CrossRef] [PubMed]
[30] Del Romero, J., Moreno Guillén, S., Rodríguez-Artalejo, F., Ruiz-Galiana, J., Cantón, R., De Lucas Ramos, P., et al. (2023) Sexually Transmitted Infections in Spain: Current Status. Revista Española de Quimioterapia, 36, 444-465. [Google Scholar] [CrossRef] [PubMed]
[31] 孙利光. 性传播疾病的防治策略[J]. 内蒙古医学杂志, 2011, 43(S5): 39-40.

为你推荐